Morgan Stanley 13D and 13G filings for Pulmonx Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-07 11:47 am Purchase | 2025-03-31 | 13G | Pulmonx Corporation LUNG | MORGAN STANLEY MS | 3,390,737 8.500% | 425,542 (+14.35%) | Filing |
| 2025-02-04 12:45 pm Sale | 2024-12-31 | 13G | Pulmonx Corporation LUNG | MORGAN STANLEY MS | 2,965,195 7.500% | -687,265 (-18.82%) | Filing |
| 2024-11-08 10:35 am Purchase | 2024-09-30 | 13G | Pulmonx Corporation LUNG | MORGAN STANLEY MS | 3,652,460 9.300% | 1,590,702 (+77.15%) | Filing |
| 2024-02-09 10:21 am Purchase | 2023-12-31 | 13G | Pulmonx Corporation LUNG | MORGAN STANLEY MS | 2,061,758 5.400% | 110,168 (+5.65%) | Filing |
| 2023-02-10 2:30 pm Purchase | 2022-12-30 | 13G | Pulmonx Corporation LUNG | MORGAN STANLEY MS | 1,951,590 5.200% | 1,951,590 (New Position) | Filing |